ATHA
Athira Pharma (ATHA)
$44
About Athira Pharma (ATHA)
Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.
Details
Daily high
$0.45
Daily low
$0.41
Price at open
$0.41
52 Week High
$4.30
52 Week Low
$0.41
Market cap
17.0M
Dividend yield
0.00%
Volume
445
Avg. volume
569,575
P/E ratio
-.15
Athira Pharma News
Details
Daily high
$0.45
Daily low
$0.41
Price at open
$0.41
52 Week High
$4.30
52 Week Low
$0.41
Market cap
17.0M
Dividend yield
0.00%
Volume
445
Avg. volume
569,575
P/E ratio
-.15